BridgeBio Pharma, Inc. Banner Image

BridgeBio Pharma, Inc.

  • Ticker BBIO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
BridgeBio Pharma, Inc. Logo Image
  • 201-500 Employees
  • Based in Palo Alto, California
BridgeBio is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. BridgeBio was founded in 2015 to identify and advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancersMore with clear genetic drivers. BridgeBio’s pipeline of over 20 development programs includes product candidates ranging from early discovery to late-stage development.
4.8 / 5.0 (108)

BridgeBio Pharma, Inc. reports have an aggregate usefulness score of 4.8 based on 108 reviews.

BridgeBio Pharma, Inc.

Most Recent Annual Report

BridgeBio Pharma, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

BridgeBio Pharma, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!